BNP Paribas Financial Markets
MRKR icon

BNP Paribas Financial Markets’s Marker Therapeutics MRKR Stock Holding History

BNP Paribas Financial Markets’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34 Hold
23
– – ﹤0.01% 5839
2026
Q1 		$30 Hold
23
– – ﹤0.01% 5739
2025
Q4 		$34 Hold
23
– – ﹤0.01% 5657
2025
Q3 		$21 Hold
23
– – ﹤0.01% 5500
2025
Q2 		$35 Hold
23
– – ﹤0.01% 5371
2025
Q1 		$28 Hold
23
– – ﹤0.01% 5312
2024
Q4 		$72 Buy
+23
New +$81 ﹤0.01% 5298
2023
Q1 		– Sell
-24
Closed -$64 – 3984
2022
Q4 		$64 Hold
24
– – ﹤0.01% 3967
2022
Q3 		$88 Hold
24
– – ﹤0.01% 4654
2022
Q2 		$79 Sell
24
-7
-23% -$23 ﹤0.01% 4026
2022
Q1 		$135 Buy
31
+7
+29% +$40 ﹤0.01% 4087
2021
Q4 		$227 Sell
24
-9
-27% -$120 ﹤0.01% 4144
2021
Q3 		$553 Sell
33
-13
-28% -$266 ﹤0.01% 3920
2021
Q2 		$1.29K Sell
46
-508
-92% -$13.4K ﹤0.01% 3926
2021
Q1 		$12.4K Buy
554
+44
+9% +$1.01K ﹤0.01% 3812
2020
Q4 		$7.39K Sell
510
-247
-33% -$3.83K ﹤0.01% 3943
2020
Q3 		$11.3K Buy
757
+514
+212% +$9.38K ﹤0.01% 3946
2020
Q2 		$5.02K Sell
243
-593
-71% -$13K ﹤0.01% 4007
2020
Q1 		$15.9K Buy
836
+457
+121% +$11.6K ﹤0.01% 3957
2019
Q4 		$10.9K Buy
379
+35
+10% +$1.27K ﹤0.01% 4117
2019
Q3 		$17.6K Buy
344
+337
+4,814% +$19.9K ﹤0.01% 4002
2019
Q2 		$554 Buy
+7
New +$416 ﹤0.01% 4398

Other funds holding MRKR

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's MRKR Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 23 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #5839.

BNP Paribas Financial Markets first reported a position in MRKR in Q2 2019 and has held it in 22 quarters since. The position peaked at $17.6K in Q3 2019. 25 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • BNP Paribas Financial Markets held 23 shares of Marker Therapeutics worth $34 as of Q2 2026.
  • BNP Paribas Financial Markets left its Marker Therapeutics share count unchanged in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5839 holding.
  • BNP Paribas Financial Markets first reported a position in Marker Therapeutics in Q2 2019 and has held it in 22 quarters since.
  • BNP Paribas Financial Markets's Marker Therapeutics position peaked at $17.6K in Q3 2019.
  • 25 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.